Solvent selection and all handling are determined by the receiving laboratory under its own protocols
Diarrhea is one of the most commonly reported side effects in retatrutide clinical trials, affecting anywhere from 9% to 35% of participants depending on dose level and study phase
Reference: Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial by Sean Wharton, Paula Freitas, Jran Hjelmesth, Maria Kabisch, Kristian Kandler, Ildiko Lingvay, Maria Quiroga, Julio Rosenstock and W Timothy Garvey, 14 September 2025, The Lancet Diabetes & Endocrinology
This involves regular check-ups and possibly adjusting dosages based on the patient's feedback and clinical indicators
GLP-1 receptor signalling promotes -cell glucose metabolism via mTOR-dependent HIF-1 activation [2]
Body composition analysis, waist circumference measurements, and certain imaging tests can help assess visceral fat levels